par Zardavas, Dimitros 
;Ades Moraes, Felipe ;de Azambuja, Evandro
Référence Expert review of anticancer therapy, 13, 11, page (1249-1256)
Publication Publié, 2013
;Ades Moraes, Felipe ;de Azambuja, Evandro Référence Expert review of anticancer therapy, 13, 11, page (1249-1256)
Publication Publié, 2013
Article révisé par les pairs
| Titre: |
|
| Auteur: | Zardavas, Dimitros; Ades Moraes, Felipe; de Azambuja, Evandro |
| Informations sur la publication: | Expert review of anticancer therapy, 13, 11, page (1249-1256) |
| Statut de publication: | Publié, 2013 |
| Sujet CREF: | Cancérologie |
| Pharmacologie | |
| Mots-clés: | adjuvant therapy |
| breast cancer | |
| HER2-positive | |
| trastuzumab | |
| MeSH keywords: | Antibodies, Monoclonal, Humanized -- therapeutic use |
| Antineoplastic Agents -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- immunology -- metabolism | |
| Chemotherapy, Adjuvant | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Receptor, ErbB-2 -- metabolism | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7140 |
| info:doi/10.1586/14737140.2013.848168 | |
| info:scp/84887307312 | |
| info:pmid/24138446 |
